287 related articles for article (PubMed ID: 27570070)
1. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones.
Amini Z; Fatemi MH; Gharaghani S
Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors.
Jadav P; Bahekar R; Shah SR; Patel D; Joharapurkar A; Jain M; Sairam KV; Singh PK
Bioorg Med Chem Lett; 2014 Apr; 24(8):1918-22. PubMed ID: 24675378
[TBL] [Abstract][Full Text] [Related]
4. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
5. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.
Agrawal R; Jain P; Dikshit SN; Bahare RS
Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
Hermansyah O; Bustamam A; Yanuar A
Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
[TBL] [Abstract][Full Text] [Related]
9. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.
Pissurlenkar RR; Shaikh MS; Coutinho EC
J Mol Model; 2007 Oct; 13(10):1047-71. PubMed ID: 17676345
[TBL] [Abstract][Full Text] [Related]
11. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.
Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399
[TBL] [Abstract][Full Text] [Related]
12. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.
Jiang YK
J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322
[TBL] [Abstract][Full Text] [Related]
14. Predicting DPP-IV inhibitors with machine learning approaches.
Cai J; Li C; Liu Z; Du J; Ye J; Gu Q; Xu J
J Comput Aided Mol Des; 2017 Apr; 31(4):393-402. PubMed ID: 28155089
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor.
Nojima H; Kanou K; Terashi G; Takeda-Shitaka M; Inoue G; Atsuda K; Itoh C; Iguchi C; Matsubara H
BMC Struct Biol; 2016 Aug; 16():11. PubMed ID: 27491540
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking studies and 2D analyses of DPP-4 inhibitors as candidates in the treatment of diabetes.
Pantaleão SQ; Maltarollo VG; Araujo SC; Gertrudes JC; Honorio KM
Mol Biosyst; 2015 Nov; 11(11):3188-93. PubMed ID: 26399297
[TBL] [Abstract][Full Text] [Related]
17. Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).
Paliwal S; Seth D; Yadav D; Yadav R; Paliwal S
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):129-40. PubMed ID: 21299434
[TBL] [Abstract][Full Text] [Related]
18. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
19. Effects of Different Dietary Flavonoids on Dipeptidyl Peptidase-IV Activity and Expression: Insights into Structure-Activity Relationship.
Gao F; Fu Y; Yi J; Gao A; Jia Y; Cai S
J Agric Food Chem; 2020 Oct; 68(43):12141-12151. PubMed ID: 33063510
[TBL] [Abstract][Full Text] [Related]
20. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
Al-Masri IM; Mohammad MK; Taha MO
ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
